- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06519435
Non-invasive Venous Air Plethysmography Assessment of Venous Hemodynamics in Patients Suspected Deep Venous Obstruction Used in Conjunction With Intermittent Pneumatic Compression.
October 25, 2025 updated by: Damon E. Houghton, Mayo Clinic
The purpose of this research is to measure changes in venous blood flow with an air-filled bladder under an intermittent pneumatic compression device cuff (used to prevent deep venous thrombosis) or venous diagnostic device cuff (used to detect deep venous thrombosis).
The devices being used in the study are investigational and not FDA-cleared.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David Liedl
- Phone Number: 507-266-6717
- Email: liedl.david@mayo.edu
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic
-
Contact:
- David Liedl
- Phone Number: 800-664-4542
- Email: liedl.david@mayo.edu
-
Contact:
- Gonda Vascular Center
- Phone Number: 507-266-6717
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Subjects with venous ultrasound evaluation performed to rule out deep vein thrombosis
Description
Inclusion Criteria:
- Venous ultrasound study to evaluate for lower extremity DVT unilateral and/or bilateral within previous 72 hours.
Exclusion Criteria:
- Patients with inaccessible target limb (ultrasound limb) due to bandages (wound, burn, lesion, etc) or cast.
- Patients with leg trauma, fracture, above or below knee amputation, or other condition in which compressing on the calf is medically inappropriate or not possible.
- Patients unable to provide informed written consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mayo Dopplex ABllity device Venous hemodynamic pressure
Time Frame: Baseline
|
Venous hemodynamic pressure to be measured from both the recumbent and sitting positions using the Mayo Dopplex ABllity device.
Measured as mmHg.
|
Baseline
|
|
Intermittent Pneumatic Compression device Venous hemodynamic pressure
Time Frame: Baseline
|
Venous hemodynamic pressure to be measured from both the recumbent and sitting positions using the IPC device.
Measured as mmHg.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Damon Houghton, MD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
April 1, 2027
Study Registration Dates
First Submitted
July 19, 2024
First Submitted That Met QC Criteria
July 19, 2024
First Posted (Actual)
July 25, 2024
Study Record Updates
Last Update Posted (Estimated)
October 28, 2025
Last Update Submitted That Met QC Criteria
October 25, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-012242
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Vein Thrombosis
-
University of OklahomaPfizerCompleted
-
University Medical Center GroningenCompletedSuspected Upper Extremity Deep Vein ThrombosisAustria, Netherlands, Italy, Belgium, Switzerland, Germany, United States
-
National Taiwan University HospitalUnknownUpper Extremity Deep Vein Thrombosis, SecondaryTaiwan
-
University of Missouri-ColumbiaTerminatedDEEP VEIN THROMBOSISUnited States
-
Vetex Medical Ltd.CompletedDeep Vein Thrombosis LegIreland, Germany, Bulgaria, United Kingdom
-
Children Hospital and Institute of Child Health...CompletedDeep Vein Thrombosis (DVT)Pakistan
-
Chinese PLA General HospitalRecruiting
-
UPECLIN HC FM Botucatu UnespCompletedProphylaxis of Deep Vein ThrombosisBrazil
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)CompletedSuspected Deep Vein ThrombosisCanada
-
Diakron PharmaceuticalsCompleted
Clinical Trials on Mayo Dopplex ABIlity
-
Stephen WhitesideNational Institute of Mental Health (NIMH)Completed
-
University of OttawaCompletedBurnout, Professional | Stress, Emotional | ResilienceCanada
-
Mayo ClinicTerminatedGastroesophageal Reflux | Hernia, Hiatal | Surveys and Questionnaires | FundoplicationUnited States
-
Stephen WhitesideNational Institute of Mental Health (NIMH)Completed
-
Mayo ClinicTerminatedPatient Education in Radiation OncologyUnited States
-
Université Polytechnique de Bobo-DioulassoUnknown
-
LEO PharmaCompletedPsoriasis VulgarisBelgium, Czechia, Germany, Italy, Spain, Poland, France, Hungary, Greece, Netherlands, United Kingdom
-
University of Alabama, TuscaloosaCompleted